Abstract: A pressurized aerosol and concentrate are described for treating moderate to severe foot and/or shoe odors. The aerosol contains micronized zinc oxide, a propellant and a solvent. Optionally, the aerosol may also contain a fragrance, a thickening agent and/or a base.

Abstract: Disclosed are formulations for topical application, the formulation comprising a C15 branched polyalphaolefin, an aqueous phase, a non-aqueous phase, and at least one sunscreen active agent, alone or in combination with an insect repellant.

Abstract: An aqueous-based sprayable composition comprises a therapeutic or palliative agent, water and a mixture of microcrystalline cellulose and alkali metal carboxyalkylcellulose. In one embodiment, the composition is a non-Newtonian nasal spray exhibiting a very rapid viscosity recovery upon removal of shear forces.

Abstract: Novel formulations combining a non-steroidal anti-inflammatory drug (NSAID) such as flunixin, with a fluorinated chloramphenicol or thiamphenicol derivative antibiotic such as florfenicol are disclosed. Methods for using such formulations in the treatment and prevention of infectious diseases of bovines and swine, including bovine respiratory disease and swine respiratory disease, are also disclosed.

Abstract: A liquid formulation comprising ribavirin having a longer shelf life and improved taste is disclosed.

Abstract: A wart, callus and/or corn removing pad including a layer of hydrocolloid adhesive material having a periphery and an underside, a medicated plaster secured centrally to the underside of the layer of hydrocolloid adhesive material and including salicylic acid therein, a barrier layer interposed between the medicated plaster and the layer of hydrocolloid adhesive material to prevent diffusion of the salicylic acid in the medicated plaster to the layer of hydrocolloid adhesive material, an outer layer secured to the layer of hydrocolloid material, the outer layer at least having a border extending outwardly of the layer of hydrocolloid adhesive material, the border having an underside, a layer of adhesive material on the underside of the border, a release liner releasably secured to the underside of the hydrocolloid adhesive layer, and a paper release tab releasably secured to an upper surface of at least one of the hydrocolloid adhesive layer and the outer layer at one side thereof.

Abstract: An insole includes a forefoot portion having a lower first recess; a cupped heel portion having a lower second recess; a mid-foot portion connecting together the forefoot portion and the heel portion, the mid-foot portion including a medial arch portion, and the forefoot, heel and mid-foot portions formed from a unitary resilient material; a plurality of protuberances in the second recess and having lower edges generally coplanar with a lower surface of the heel portion in surrounding relation to the second recess; a plurality of spaced apart spring walls formed from a viscoelastic gel in the first recess, the spring walls having lower edges generally coplanar with a lower surface of the forefoot portion which is in surrounding relation to the first recess; and a shell extending under the mid-foot portion and made of a resilient material that is stiffer than the unitary resilient material.

Abstract: A removable insole for insertion into footwear, includes a lower layer made of a viscoelastic gel and including a lower surface, an upper surface, a toe portion, a heel portion and a medial arch portion interconnecting the toe portion and the heel portion, a first recess formed in the lower surface of the toe portion and a second recess formed in the lower surface of the heel portion, each recess having a peripheral side wall and a top wall, a plurality of thin, parallel, spaced apart sinusoidal wave shaped spring walls formed from the viscoelastic gel and connected to the top wall and the peripheral side wall in each recess, and the spring walls having lower edges generally coplanar with a lower surface of the toe portion and heel portion which is in surrounding relation to the respective recess; and a top cover secured to the upper surface of the lower layer.

Abstract: A method of treating and/or preventing allergic and inflammatory conditions of the skin or airway passages in a human in need of such treating and/or preventing which comprises administering to said human an effective amount of a nonsedating antihistamine for such treating and/or preventing while avoiding the side effects associated with other nonsedating antihistamines that bind to the P-glycoprotein pump and/or the organic anion transport polypeptide pump is disclosed.

Abstract: The invention relates to a method of producing an agglomerate of drug and solid binder. The process involves producing individual agglomerate particles and then converting the convertible amorphous content of same, following agglomeration, by the application of, for example, moisture. Agglomerates capable of conversion as well as the finished agglomerates and oral and nasal dosing systems including same are also contemplated. The process produces agglomerates which are rugged but which will produce an acceptable fine particle fraction during dosing.

Abstract: The invention relates to a method of producing an agglomerate of drug and solid binder. The process involves producing individual agglomerate particles and then converting the convertible amorphous content of same, following agglomeration, by the application of, for example, moisture. Agglomerates capable of conversion as well as the finished agglomerates and oral and nasal dosing systems including same are also contemplated. The process produces agglomerates which are rugged but which will produce an acceptable fine particle fraction during dosing.

Abstract: Disclosed are skin care compositions that are emulsion formulations comprising an aqueous phase, an oil phase, at least one emulsifier, and an epichlorohydrin cross-linked glyceryl starch.

Abstract: A removable insole for insertion into footwear, includes a forefoot portion extending at least to metatarsals of a foot, the forefoot portion including a combination layer formed from a bottom layer of a resilient foam material which provides a shock absorption cushioning function, and a top layer of a slow recovery material which absorbs shear forces applied to the second layer at pressure points and spreads out the shear forces along the forefoot portion, the top layer being of substantially the same dimensions as the bottom layer and superposed therewith, the bottom and top layers having the same thickness and outer dimensions; a cupped heel portion formed by a relatively flat central portion and a sloped side wall; a mid-foot portion connecting together the forefoot portion and the heel portion, the mid-foot portion including a medial arch portion and being connected to the forefoot portion at the medial arch portion, the heel portion and mid-foot portion together being formed by a unitary layer of resili

Abstract: The present invention provides methods of treatment of mental and vascular disorders. In one embodiment, the present invention contemplates the administration of an anti-allergic medication to reduce a patient's symptoms of mental or vascular disorder. The patient may or may not suffer from allergic responses. Likewise, the methods of the present invention may be used to reduce or prevent the symptoms of a mental or vascular disorder. In a preferred embodiment, the anti-allergic medication is a non-sedating or low-sedating antihistamine such as loratadine or desloratadine.

Abstract: A wart, callus and/or corn removing pad including a layer of hydrocolloid adhesive material having a periphery and an underside, a medicated plaster secured centrally to the underside of the layer of hydrocolloid adhesive material and including salicylic acid therein, a barrier layer interposed between the medicated plaster and the layer of hydrocolloid adhesive material to prevent diffusion of the salicylic acid in the medicated plaster to the layer of hydrocolloid adhesive material, an outer layer secured to the layer of hydrocolloid material, the outer layer at least having a border extending outwardly of the layer of hydrocolloid adhesive material, the border having an underside, a layer of adhesive material on the underside of the border, a release liner releasably secured to the underside of the hydrocolloid adhesive layer, and a paper release tab releasably secured to an upper surface of at least one of the hydrocolloid adhesive layer and the outer layer at one side thereof.

Abstract: A method and a medicament for treating onychomycosis. The active ingredient is salicylic acid or a salt, ester or mixture thereof in a medicament, such as a plaster preparation or a liquid preparation, optionally with a retinoid compound such as tretinoin, adapalene, manoalide, retinol, tretinate or mixtures thereof. The method comprises topically administering the active ingredient to the afflicted nail. The medicament is applied without drilling holes in the nail or periodic scraping of the nail and in the absence of an imidazole antimycotic compound.

Abstract: Disclosed are skin care compositions that are emulsion formulations comprising an aqueous phase, an oil phase, at least one emulsifier, and an epichlorohydrin cross-linked glyceryl starch.